D. E. Shaw & Co., Inc. Invitae Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $188,400 - $467,700	-30,000 Reduced 40.54%	44,000 $351,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $1.07 Million - $1.48 Million	44,000 Added 146.67%	74,000 $2.1 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $978,375 - $1.52 Million	-37,500 Reduced 55.56%	30,000 $1.01 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $1.33 Million - $1.96 Million	-34,100 Reduced 33.56%	67,500 $2.82 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $1.19 Million - $3.08 Million	101,600 New	101,600 $3.08 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.